(0)

Voco Orchard Singapore, an IHG Hotel

Jul 16, 2024 8:30 AM - Jul 17, 2024 5:30 PM

581, Orchard Road, Singapore 238883, Singapore

2024 DIA Singapore Annual Meeting

Cultivating Synergies in Clinical Research and the Regulatory Environment to Innovate Healthcare

Overview

The rapid evolution of drug development and technology, coupled with regulatory advances have created new opportunities and challenges in healthcare. It is critical for regulators, academia, patients, and industries to collaborate closely to ensure an evolving and robust regulatory ecosystem that enables accelerated and cost-effective access to innovative healthcare solutions. This year, DIA Singapore Annual Meeting aims to bring regulators, patient representatives and industries to share and discuss ways in cultivating synergies in clinical research and the regulatory environment to innovate healthcare in APAC. Come join us and be a part of the discussions to explore the challenges and actions that stakeholders in APAC can adopt to ensure transformations in the healthcare evolution.

View Program

Featured topics

  • Future regulatory ecosystem
  • Accelerating and Streamlining Accelerating Procedures
  • Drug Development and Innovation in Clinical Research
  • New Regulatory Fields and Trends
  • The influence of emerging regulatory strategies and trends on the surveillance of medicines after they have been approved
  • Clinical Research Regulations

Featured

Want to learn more about 2024 DIA Singapore Annual Meeting? You've come to the right site!

Exhibits

Learn more

Learning objectives

• Receive updates from senior regulators how healthcare products are regulated, what actions/ plans they have for regulating innovative products and clinical trials, and their collaborations with key stakeholders.

• Hear the dialogues between regulators, patient representatives and industries on Clinical Research and the Product Registration topics.

• Receive the information on hot regulatory topics, such as ICH guidelines, AI, and new technologies adopted in R&D.

• ASEAN Townhall: Hear deliberation about the topics discussed at this DIA Singapore from the ASEAN countries regulators.

• Network with regulators, patient representatives, clinical development, pharmacovigilance and regulatory affairs professionals from industries.

Program Committee

  • Finny Liu, MSc, RPh
    Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
    Roche, Singapore
  • Helene Sou, MSc, RAC
    Helene Sou, MSc, RAC Global Regulatory Policy and Innovation
    Takeda Pharmaceutical Company Limited., Singapore
  • Sandy Chan
    Sandy Chan Associate Director, Regulatory Policy & Intelligence Lead- Asia Pacific
    Johnson & Johnson, Singapore
  • Martin Lim, MBA, MS
    Martin Lim, MBA, MS Co-Founder and CEO
    ONWARD Health Research, Singapore
  • Thean Soo Lo
    Thean Soo Lo
    Regulatory Affairs Management Consultant, Singapore
  • Edana Loke
    Edana Loke Assoc Dir - Asia, Australia, Africa, Middle East, Area & Affiliate Strategy
    AbbVie Pte Ltd, Singapore
  • Karin Markgraf
    Karin Markgraf Head Regulatory Affairs, APAC
    Merck Pte Ltd, Singapore
  • Audrey Ooi, MSc
    Audrey Ooi, MSc Head- Business Development
    Clinical Research Malaysia, Malaysia

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.